Babakinejad P, Hampton PJ. New brodalumab psoriasis outcome data suggests that intermittent treatment is as effective as continuous dosing. Is it time to re-evaluate our treatment regimens? Br J Dermatol 2020;183:984-985.
PMID: 33316092